Skip to main content
    V

    Vivani Medical Inc. (VANI)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.02
    +0.01 (+0.99%)

    Market Cap: $91.11M

    Last updated: Nov 17, 2026 at 11:03 AM ET

    Vivani Medical Inc. (VANI) Financials: Revenue, Profit and Cash Flow

    Updated Nov 11, 2026. Financial statements from company filings, amounts in US dollars.

    Vivani Medical reported revenue of $0 for the fiscal year ended Dec 31, 2025. That year, net income was -$26.61M, operating cash flow was -$24.32M and free cash flow was -$25.49M. The quarter ended Sep 30, 2026 had revenue of $0 and net income of -$7.25M.

    Revenue and Margins

    The company reported no revenue in the fiscal year ended Dec 2025, with an operating loss of $27.56M.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$0N/AN/AN/AN/A
    Dec 2024$0N/AN/AN/AN/A
    Dec 2023$0N/AN/AN/AN/A
    Dec 2022$0N/AN/AN/AN/A
    Dec 2021$0N/AN/AN/AN/A
    Dec 2020$0-100.0%N/AN/AN/A
    Dec 2019$3.38M-51.0%36.3%-1004.9%-994.1%
    Dec 2018$6.90M-13.4%29.1%-510.2%-508.9%
    Dec 2017$7.96M+99.8%35.7%-359.2%-358.1%
    Dec 2016$3.98MN/A-152.8%-833.4%-832.6%
    Annual, fiscal years ended Dec 2016 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, the net loss widened from the year before. In the quarter ended Sep 2026, the net loss widened from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Revenue$0$0$0$0$0$0$3.38M$6.90M$7.96M$3.98M
    Cost of revenue$0$0$0$0$0$500.00K$2.15M$4.89M$5.12M$10.08M
    Gross profit$0$0$0$0$0$500.00K$1.23M$2.01M$2.85M-$6.09M
    Research and development$18.13M$15.74M$16.97M$14.17M$11.00M$4.84M$13.14M$10.01M$7.89M$5.35M
    Operating income-$27.56M-$24.68M-$26.96M-$21.24M-$13.32M-$14.90M-$33.95M-$35.18M-$28.61M-$33.21M
    Net income-$26.61M-$23.49M-$25.65M-$13.89M-$12.77M-$14.88M-$33.59M-$35.09M-$28.52M-$33.18M
    EBITDA-$26.18M-$23.09M-$25.70M-$20.86M-$12.98M-$14.73M-$33.56M-$34.74M-$28.15M-$32.78M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$0$0$0$0$0$0$0$398.00K$0$0$0$518.00K
    Gross profit$0$0$0-$115.00K$0$0$0-$89.00K$0$0$0-$98.00K
    Operating income-$7.53M-$6.87M-$6.82M-$6.81M-$6.72M-$7.46M-$6.56M-$6.46M-$6.31M-$5.68M-$6.23M-$6.22M
    Net income-$7.25M-$6.37M-$6.78M-$6.63M-$6.53M-$7.14M-$6.30M-$6.05M-$6.04M-$5.36M-$6.04M-$6.03M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, cash and equivalents exceeded short-term debt of $1.79M by $14.44M.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Total assets$39.39M$41.56M$45.80M$51.13M$5.45M$4.46M$16.60M$10.68M$14.50M$16.81M
    Current assets$17.90M$20.44M$23.06M$47.53M$2.47M$4.27M$13.11M$9.62M$13.16M$15.28M
    Cash and equivalents$16.23M$18.35M$20.65M$45.08M$2.18M$3.18M$11.33M$4.47M$7.84M$539.00K
    Total liabilities$23.66M$23.95M$25.04M$6.82M$2.99M$5.13M$9.32M$7.60M$6.62M$5.66M
    Short-term debt$1.79M$1.35M$1.38M$955.00K$910.00K$2.20M$0N/AN/AN/A
    Shareholder equity$15.73M$17.61M$20.76M$44.31M$2.46M-$672.00K$7.28M$3.08M$7.88M$11.15M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$35.31M$41.64M$42.35M$39.39M$25.05M$28.91M$35.45M$41.56M$42.90M$48.22M$53.79M$45.80M
    Total liabilities$22.09M$22.67M$23.27M$23.66M$23.74M$24.00M$23.83M$23.95M$24.56M$24.40M$25.08M$25.04M
    Cash and equivalents$14.59M$19.89M$19.75M$16.23M$2.63M$6.79M$13.01M$18.35M$19.65M$24.92M$29.65M$20.65M
    Shareholder equity$13.22M$18.97M$19.09M$15.73M$1.31M$4.91M$11.62M$17.61M$18.33M$23.82M$28.71M$20.76M
    Last 12 quarters

    Cash Flow

    Operating cash flow was negative in the fiscal year ended Dec 2025.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Operating cash flow-$24.32M-$20.79M-$23.70M-$18.79M-$10.95M-$16.82M-$27.63M-$29.81M-$23.95M-$25.07M
    Capital expenditures$1.17M$556.00K$887.00K$338.00K$572.00K$330.00K$493.00K$163.00K$265.00K$490.00K
    Free cash flow-$25.49M-$21.34M-$24.59M-$19.13M-$11.52M-$17.15M-$28.12M-$29.97M-$24.21M-$25.56M
    Share repurchasesN/A$13.69M$0N/AN/A$281.00K$0N/AN/AN/A
    Investing cash flow-$1.17M-$556.00K-$887.00K-$338.00K-$572.00K$68.00K-$493.00K-$163.00K-$265.00K-$490.00K
    Financing cash flow$23.27M$19.05M$133.00K$63.39M$11.62M$8.60M$34.99M$26.60M$21.17M$20.45M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow-$6.39M-$6.04M-$6.20M-$6.72M-$6.35M-$6.09M-$5.16M-$5.81M-$5.66M-$4.80M-$4.51M-$3.48M
    Capital expendituresN/A$99.00K$3.00K$274.00K$823.00K$71.00K$5.00K$296.00K$41.00K$37.00K$182.00K$743.00K
    Free cash flowN/A-$6.13M-$6.20M-$6.99M-$7.17M-$6.16M-$5.17M-$6.11M-$5.70M-$4.84M-$4.69M-$4.22M
    Last 12 quarters

    Frequently Asked Questions About VANI

    What is Vivani Medical's annual revenue?

    Vivani Medical reported revenue of $0 for the fiscal year ended Dec 31, 2025.

    Is Vivani Medical profitable?

    No. Vivani Medical reported net income of -$26.61M for the fiscal year ended Dec 31, 2025.

    How much free cash flow does VANI generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of -$24.32M minus capital expenditures of $1.17M produced free cash flow of -$25.49M.

    How much debt does Vivani Medical have?

    The balance sheet dated Dec 31, 2025 reported short-term debt of $1.79M and cash and equivalents of $16.23M.